Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
+$556M |
| 2 |
Eaton
ETN
|
+$521M |
| 3 |
Verisk Analytics
VRSK
|
+$352M |
| 4 |
Zimmer Biomet
ZBH
|
+$343M |
| 5 |
iShares Core MSCI International Developed Markets ETF
IDEV
|
+$340M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$677M |
| 2 |
Lockheed Martin
LMT
|
+$569M |
| 3 |
Booz Allen Hamilton
BAH
|
+$491M |
| 4 |
Microsoft
MSFT
|
+$489M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$419M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.21% |
| 2 | Financials | 11.94% |
| 3 | Healthcare | 8.99% |
| 4 | Industrials | 8.12% |
| 5 | Consumer Discretionary | 7.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3876
Talkspace
TALK
$873M
| $46.9K | ﹤0.01% |
18,321
+1,146
| +7% | +$3.57K |
|
|
JMIA
3877
Jumia Technologies
JMIA
$738M
| $46.2K | ﹤0.01% |
21,482
-3,235
| -13% | -$10.5K |
|
3878
Gray Television
GTN
$415M
| $45.5K | ﹤0.01% |
10,536
-5
| -0% | -$20 |
|
3879
Amylyx Pharmaceuticals
AMLX
$2.26B
| $45.3K | ﹤0.01% |
12,805
-37,623
| -75% | -$134K |
|
3880
Cipher Digital
CIFR
$9.13B
| $44.5K | ﹤0.01% |
19,348
-10,271
| -35% | -$46.7K |
|
3881
1stdibs.com
DIBS
$150M
| $43.3K | ﹤0.01% |
14,240
-5,264
| -27% | -$18.9K |
|
3882
Chegg
CHGG
$110M
| $42.8K | ﹤0.01% |
66,920
-199,735
| -75% | -$247K |
|
|
NBIS
3883
Nebius Group N.V.
NBIS
$48.3B
| $39.3K | ﹤0.01% |
+1,863
| New | +$61.3K |
|
3884
Tilray
TLRY
$620M
| $37.2K | ﹤0.01% |
5,651
-563
| -9% | -$5.21K |
|
|
LPRO
3885
Open Lending Corp
LPRO
| $36.8K | ﹤0.01% |
13,317
-86
| -0.6% | -$427 |
|
3886
Vuzix
VUZI
$195M
| $36.3K | ﹤0.01% |
17,800
+500
| +3% | +$1.64K |
|
3887
Cerus
CERS
$431M
| $36.3K | ﹤0.01% |
26,115
-153
| -0.6% | -$256 |
|
3888
Savara
SVRA
$1.12B
| $34.9K | ﹤0.01% |
12,588
+449
| +4% | +$1.24K |
|
3889
Sana Biotechnology
SANA
$868M
| $33.1K | ﹤0.01% |
19,729
+2,088
| +12% | +$5.84K |
|
3890
Alto Neuroscience
ANRO
$1.05B
| $33K | ﹤0.01% |
15,269
-6,746
| -31% | -$24.1K |
|
3891
Taysha Gene Therapies
TSHA
$1.69B
| $31.8K | ﹤0.01% |
22,844
-149
| -0.6% | -$249 |
|
|
URG
3892
Ur-Energy
URG
$481M
| $31.4K | ﹤0.01% |
46,543
-274
| -0.6% | -$269 |
|
3893
BRC Inc
BRCC
$121M
| $30.6K | ﹤0.01% |
14,652
-40
| -0.3% | -$102 |
|
3894
ChargePoint
CHPT
$141M
| $29.5K | ﹤0.01% |
2,441
-427
| -15% | -$7.12K |
|
3895
Ocugen
OCGN
$423M
| $26.9K | ﹤0.01% |
38,102
+557
| +1% | +$385 |
|
3896
Ambev
ABEV
$47.9B
| $25.3K | ﹤0.01% |
10,855
-10,482
| -49% | -$21K |
|
3897
Kaltura
KLTR
$206M
| $23.9K | ﹤0.01% |
12,704
-83
| -0.6% | -$186 |
|
|
EU
3898
enCore Energy
EU
$210M
| $23.8K | ﹤0.01% |
17,344
-4,013
| -19% | -$10.3K |
|
|
ORGN
3899
DELISTED
Origin Materials
ORGN
| $23.6K | ﹤0.01% |
1,184
-5,742
| -83% | -$158K |
|
3900
Akebia Therapeutics
AKBA
$354M
| $23.1K | ﹤0.01% |
12,052
+86
| +0.7% | +$176 |
|
Similar funds
Ameriprise's Q1 2025 Portfolio in Review
As of Q1 2025, Ameriprise held 4,203 positions worth $370B, down 4.9% from $390B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ameriprise's Q1 2025 filing shows 139 new, 1,887 increased, 1,861 reduced and 193 closed positions. Its largest new stake was Sandisk: 1,344,148 shares worth $64M. The largest sale was Amazon, an estimated $677M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q1 2025 buy was Sandisk: 1,344,148 shares worth $64M.
- Ameriprise added most to iShares 0-3 Month Treasury Bond ETF in Q1 2025, an estimated $556M increase.
- Ameriprise's biggest Q1 2025 reduction was Amazon, cutting an estimated $677M.
- Ameriprise fully exited Smartsheet Inc. in Q1 2025, selling an estimated $24.3M.
- Ameriprise's ten largest holdings make up 19% of its $370B portfolio in Q1 2025.
- Ameriprise opened 139 new positions and closed 193 in Q1 2025.
- Ameriprise's portfolio value fell 4.9% quarter-over-quarter to $370B.
Based on Ameriprise's 13F filing for Q1 2025, filed 14 May 2025.